Aries Biotech extends gratitude to the Alzheimer’s Research UK team, for inviting Dr. Angela Boutte, the founder of Aries Biotech, as a contributing reviewer and panelist. Through partnerships with the Alzheimer’s Society, National Institute for Health Research (NIHR), and memory clinics across the UK, ARUK funds community based, prospective studies that determine how blood-based biomarkers can improve the AD diagnosis. Aries Biotech supports groundbreaking biomarker research and community-based medicine that address disparities in diagnostic service access.
Additional information about ARUK may be found at
Aries Biotech is a neurological disease and dementia biomarker consulting company that provides guidance, data interpretation, document review, and investor support. To learn more, visit Aries Biotech at https://www.ariesbiotechnologies.com.
Check out our community interest survey at https://forms.wix.com/f/7075978737291886849
#community #Alzheimer’s #DEI #neuroscience #neurology #neurologicaldisease #TBI #biomarker #diagnostics #IVD #vaccine #antibodytherapeutics #inhibitor #therapeutics #ml #ai #biotech #invest
Comments